Загрузка...
Liquid formulation of pentoxifylline is a poorly tolerated treatment for Duchenne dystrophy
OBJECTIVE: To perform an open label, pilot study of an orally administered liquid formulation of immediate release pentoxifylline (PTX) to patients with Duchenne muscular dystrophy (DMD). Treatment efficacy, safety and tolerability were assessed. METHODS: The tolerability and safety of PTX, measures...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3136640/ https://ncbi.nlm.nih.gov/pubmed/21674534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mus.22127 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|